speb/financial-data huggingface dataset:
Stock screener scorecard for 4633.T (annual, report date 2025-12-31)
Altman Z-score: 2.960985880281571 (Grey Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 12.447681642796415%
Earnings yield: 0.06725635354835054%
Return on net tangible assets: 11.231741723509876%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 9.30808306181956%
Free cash flow margin: 3.4396975953552635%
Revenue growth: 5.315586268337367%
Rule of 40 score: 8.75528386369263
Market cap: 113367917670.85168 (Large Cap ($10B-$200B))
P/E ratio: 8.6158928158422
Debt to equity: 0.2655611498849957
Free cash flow (dilution adjusted): 56665174.86094239
Operating income: 97353110.41493511
Net income: 84125055.94271466
Long score: 9 | Short score: 1
Recommendation: Long
Stock screener scorecard for 6481.T (annual, report date 2025-12-31)
Altman Z-score: 2.7555970179064713 (Grey Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 4.61891034880369%
Earnings yield: 0.012611631867772569%
Return on net tangible assets: -26.915656863048937%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.3000450856627594%
Revenue growth: 8.350033947715538%
Rule of 40 score: 8.350033947715538
Market cap: 444746797371.6237 (Mega Cap (>= $200B))
Debt to equity: 0.463614162235794
Operating income: 102442299.08573622
Net income: -444210728.21430856
Long score: 3 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for AF.PA (annual, report date 2025-12-31)
Altman Z-score: 0.912364845695489 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 11.096484010750917%
Earnings yield: 16.234551473667263%
Return on net tangible assets: -172.9537366548043%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 9.058749776106035%
Free cash flow margin: 1.8299148665434601%
Revenue growth: 18.498662124184044%
Rule of 40 score: 20.328576990727505
Market cap: 3033806665.88 (Mid Cap ($2B-$10B))
P/E ratio: 1.7296503226225772
Debt to equity: 6.513536379018616
Free cash flow (dilution adjusted): 710588235.2941176
Operating income: 2380000000
Net income: 2063529411.764706
Long score: 7 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for ERII (annual, report date 2025-12-31)
Altman Z-score: 19.0315084464702 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 13.118183986297508%
Earnings yield: 6.784876586901952%
Return on net tangible assets: 13.811646208415631%
Capitalized R&D asset: 29522450
ROCI (R&D adjusted): 8.951130183291138%
Rosenberg metric: -0.5544469081054447
Free cash flow margin: 7.201434212183395%
Revenue growth: -6.872119656704473%
Rule of 40 score: 0.3293145554789225
Market cap: 695345543.91 (Small Cap ($300M-$2B))
P/E ratio: 30.282446821269925
Debt to equity: 0.045729223248234654
Free cash flow (dilution adjusted): 9721000
Operating income: 24202000
Net income: 22962000
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for GCP.DE (annual, report date 2025-12-31)
Altman Z-score: 3.2688355916947454 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 90.40724924487033%
Earnings yield: 2.591772531734693%
Return on net tangible assets: 162.75273604155075%
Capitalized R&D asset: 2775250000
ROCI (R&D adjusted): 9.543802142504294%
Rosenberg metric: 1.9230171073094868
Free cash flow margin: 15.841238687166067%
Revenue growth: 18.482248979380913%
Rule of 40 score: 34.32348766654698
Market cap: 322462222422.60004 (Mega Cap (>= $200B))
P/E ratio: 37.0475898923024
Debt to equity: 1.0845062969626416
Free cash flow (dilution adjusted): 7264000000
Operating income: 8680000000
Net income: 8704000000
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for LILA (annual, report date 2025-12-31)
Altman Z-score: 0.1082939518241926 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 17.480138966497414%
Earnings yield: 7.057015807150455%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.020882123341139%
Free cash flow margin: 5.661609112601864%
Revenue growth: -0.10344517405774939%
Rule of 40 score: 5.558163938544115
Market cap: 189755999.99999997 (Micro Cap ($50M-$300M))
Debt to equity: 7.874188998589562
Free cash flow (dilution adjusted): 251500000
Operating income: 719500000
Net income: -554300000
Long score: 6 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for PTON (annual, report date 2025-06-30)
Altman Z-score: -1.3808803071416653 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 5.09243974909211%
Earnings yield: 1.9069159754148797%
Capitalized R&D asset: 543488000
ROCI (R&D adjusted): 0.5415874840741106%
Rosenberg metric: 0.20275590551181102
Free cash flow margin: 3.777902681869279%
Revenue growth: -7.76181306473115%
Rule of 40 score: -3.9839103828618714
Market cap: 2895057094.94 (Mid Cap ($2B-$10B))
Debt to equity: -4.777858351462412
Free cash flow (dilution adjusted): 94100000
Operating income: 61700000
Net income: -118900000
Long score: 4 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for R3NK.DE (annual, report date 2025-12-31)
Altman Z-score: 4.251054412679594 (Safe Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 20.503474567457296%
Earnings yield: 4.101071846934994%
Return on net tangible assets: 81.27819118488837%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 14.296264498355846%
Free cash flow margin: 6.853319865024118%
Revenue growth: 35.28829978572941%
Rule of 40 score: 42.141619650753526
Market cap: 5300000000 (Mid Cap ($2B-$10B))
P/E ratio: 52.33172388597608
Debt to equity: 1.0921498641883853
Free cash flow (dilution adjusted): 110150588.23529412
Operating income: 201780000
Net income: 119149411.76470588
Long score: 10 | Short score: 1
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for RYAM (annual, report date 2025-12-31)
Altman Z-score: 1.0928471177552086 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0.9199097021151298%
Earnings yield: 0.8840132599190831%
Return on net tangible assets: -128.637824870052%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.8045190982976843%
Free cash flow margin: -6.627400356110931%
Revenue growth: -10.053989798246711%
Rule of 40 score: -16.681390154357643
Market cap: 397213053.60999995 (Small Cap ($300M-$2B))
Debt to equity: 2.37561981202847
Free cash flow (dilution adjusted): -97184000
Operating income: 11247000
Net income: -420513000
Long score: 0 | Short score: 9
Recommendation: Short
Stock screener scorecard for VNX.DE (annual, report date 2025-12-31)
Altman Z-score: 2.696915931574636 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 43.135304150085275%
Earnings yield: 5.2365398895964965%
Return on net tangible assets: -161.89944134078212%
Capitalized R&D asset: 5301081004.901961
ROCI (R&D adjusted): 11.603566506160114%
Rosenberg metric: 0.19860648136544795
Free cash flow margin: 14.842285434835764%
Revenue growth: 9.852171723295314%
Rule of 40 score: 24.69445715813108
Market cap: 46873780527.14001 (Large Cap ($10B-$200B))
P/E ratio: 22.666238165928437
Debt to equity: 1.1694574681848628
Free cash flow (dilution adjusted): 2142352941.1764705
Operating income: 3570588235.294118
Net income: 2432941176.470588
Long score: 7 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 0189.HK (annual, report date 2025-12-31)
Altman Z-score: 5.701087249766247 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 12.450658343150058%
Earnings yield: 1.5890325265527%
Return on net tangible assets: 13.666026865940637%
Capitalized R&D asset: 220362232.7165234
ROCI (R&D adjusted): 11.007444319102573%
Rosenberg metric: 2.1858303481023142
Free cash flow margin: 14.131913322258743%
Revenue growth: 5.567447786518158%
Rule of 40 score: 19.699361108776902
Market cap: 21554931712 (Large Cap ($10B-$200B))
P/E ratio: 1.2102736765475353
Debt to equity: 0.0017000000000000001
Free cash flow (dilution adjusted): 289812857.1428572
Operating income: 350989857.14285713
Net income: 311941857.14285713
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 1521.HK (annual, report date 2025-12-31)
Altman Z-score: 8.153399560592069 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 9.650486583289872%
Earnings yield: 0.8165501085201131%
Return on net tangible assets: 22.759209258182942%
Capitalized R&D asset: 10039180
ROCI (R&D adjusted): 4.1569178508576075%
Rosenberg metric: -0.10944206008583691
Free cash flow margin: 11.784597044695763%
Revenue growth: 0.6998630873220429%
Rule of 40 score: 12.484460132017807
Market cap: 2311610368 (Mid Cap ($2B-$10B))
P/E ratio: 4.284490145672665
Debt to equity: 0.3691
Free cash flow (dilution adjusted): 30250000
Operating income: 19615000
Net income: 6793000
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 1815.T (annual, report date 2026-03-31)
Altman Z-score: 1.3379964401034785 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 8.485013130489904%
Earnings yield: 0.03087377594244237%
Return on net tangible assets: 7.450380881449833%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.906315725169523%
Free cash flow margin: -8.197459738410892%
Revenue growth: -9.068382963787405%
Rule of 40 score: -17.2658427021983
Market cap: 62689173504 (Large Cap ($10B-$200B))
P/E ratio: 0.0795683464012641
Debt to equity: 0.9611
Free cash flow (dilution adjusted): -92223473.47347347
Operating income: 35172672.672672674
Net income: 31594094.094094094
Long score: 1 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 4PN.DE (quarterly, report date 2026-03-31)
Altman Z-score: 1.9447253366013868 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 5.845104724792986%
Earnings yield: 0.38626601378549824%
Return on net tangible assets: -6.192660550458716%
Capitalized R&D asset: 300030000
ROCI (R&D adjusted): 0.801586194909547%
Rosenberg metric: 1.76875
Free cash flow margin: -0.6740310803220371%
Revenue growth: 10.419681620839363%
Rule of 40 score: 9.745650540517326
Market cap: 50582347776 (Large Cap ($10B-$200B))
P/E ratio: 41.98014629049112
Debt to equity: 0.9109999999999999
Free cash flow (dilution adjusted): -36000000
Operating income: 240000000
Net income: 265000000
Long score: 3 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for 6797.T (annual, report date 2026-03-31)
Altman Z-score: 3.956642422477003 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 8.428413611774134%
Earnings yield: 0.18233235693185504%
Return on net tangible assets: 7.55286766940841%
Capitalized R&D asset: 11413179.224623814
ROCI (R&D adjusted): 6.1733959080729095%
Rosenberg metric: -1.2863429773468205
Free cash flow margin: 20.293317614414473%
Revenue growth: -6.149422521212938%
Rule of 40 score: 14.143895093201536
Market cap: 13541476352 (Large Cap ($10B-$200B))
P/E ratio: 0.0573590999122914
Debt to equity: 0
Free cash flow (dilution adjusted): 21973485.985985987
Operating income: 10944456.956956957
Net income: 9498448.448448448
Long score: 6 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for CLTN.SW (annual, report date 2025-12-31)
Altman Z-score: 6.25345819920892 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 22.550861559933434%
Earnings yield: 8.188044219323826%
Return on net tangible assets: 18.84003960944238%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 19.854435464814028%
Free cash flow margin: 3.203955891971156%
Revenue growth: 9.31897945817852%
Rule of 40 score: 12.522935350149677
Market cap: 298470784 (Micro Cap ($50M-$300M))
P/E ratio: 26.131645569620254
Debt to equity: 0.4675
Free cash flow (dilution adjusted): 9735443.037974684
Operating income: 26588607.594936706
Net income: 18915189.87341772
Long score: 11 | Short score: 2
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for CSL.AX (annual, report date 2025-06-30)
Altman Z-score: 3.3077516366115023 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 17.579610266159698%
Earnings yield: 2.8924196740454455%
Return on net tangible assets: 111.65079365079367%
Capitalized R&D asset: 1796869289.702636
ROCI (R&D adjusted): 7.932037432033795%
Rosenberg metric: 0.16370492252845198
Free cash flow margin: 16.48736228127025%
Revenue growth: 2.977882780069139%
Rule of 40 score: 19.465245061339388
Market cap: 54701326336 (Large Cap ($10B-$200B))
P/E ratio: 17.299905994863025
Debt to equity: 0.5444
Free cash flow (dilution adjusted): 1662745098.0392156
Operating income: 1933986928.1045752
Net income: 2049673202.6143792
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for FLS (quarterly, report date 2026-03-31)
Altman Z-score: 3.2660228238465603 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 4.8487748245644715%
Earnings yield: 1.1175675203696374%
Return on net tangible assets: 14.696131207713073%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.6733912609050425%
Free cash flow margin: -6.617715200946578%
Revenue growth: -12.593939899737439%
Rule of 40 score: -19.211655100684016
Market cap: 9253228544 (Mid Cap ($2B-$10B))
P/E ratio: 26.94485294117647
Debt to equity: 0.8290000000000001
Free cash flow (dilution adjusted): -70695000
Operating income: 116441000
Net income: 86369000
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for GL9.IR (annual, report date 2025-12-31)
Altman Z-score: 3.627108200837592 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 26.237197281516224%
Earnings yield: 4.9777351952094495%
Return on net tangible assets: 71.75514351028701%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 9.948461091753776%
Free cash flow margin: 6.6338941820393265%
Revenue growth: 16.07965695849401%
Rule of 40 score: 22.713551140533337
Market cap: 5824759808 (Mid Cap ($2B-$10B))
P/E ratio: 26.415441176470587
Debt to equity: 0.5841
Free cash flow (dilution adjusted): 308000000
Operating income: 322470588.2352941
Net income: 215647058.82352942
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for GLENMARK.NS (annual, report date 2026-03-31)
Altman Z-score: 5.749133923867245 (Safe Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 43.275132632991465%
Earnings yield: 0.06915702811619368%
Return on net tangible assets: 7.245373744625984%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 29.552900834722077%
Free cash flow margin: 12.330000060437774%
Revenue growth: 15.240734118871632%
Rule of 40 score: 27.570734179309405
Market cap: 618584145920 (Mega Cap (>= $200B))
P/E ratio: 0.46642538082252777
Debt to equity: 0.0565
Free cash flow (dilution adjusted): 218367528.61381942
Operating income: 423795676.13395506
Net income: 144335735.48113608
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for GLENMARK.NS (quarterly, report date 2026-03-31)
Altman Z-score: 4.537596118427831 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 6.651945599506533%
Earnings yield: 0.010630326491518459%
Return on net tangible assets: 5.6124116758667775%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.542661725092286%
Revenue growth: -7.9895855926990595%
Rule of 40 score: -7.9895855926990595
Market cap: 618584145920 (Mega Cap (>= $200B))
P/E ratio: 0.46642538082252777
Debt to equity: 0.0565
Operating income: 65142857.14285714
Net income: 31942984.315387875
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for GOKULAGRO.NS (quarterly, report date 2026-03-31)
Altman Z-score: 2.6156267414660386 (Grey Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 10.593613264095156%
Earnings yield: 0.031249670434816117%
Return on net tangible assets: 9.406940713057867%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.005796101470043%
Revenue growth: -6.582985181904734%
Rule of 40 score: -6.582985181904734
Market cap: 61947551744 (Large Cap ($10B-$200B))
P/E ratio: 0.15183647871401104
Debt to equity: 0.41409999999999997
Operating income: 19118069.09707503
Net income: 12631899.109792285
Long score: 4 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for GOKULAGRO.NS (annual, report date 2026-03-31)
Altman Z-score: 6.537199662066947 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 36.40263999851076%
Earnings yield: 0.1073826724226638%
Return on net tangible assets: 22.596299659964767%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 34.38273460622007%
Free cash flow margin: 0.9112533971349115%
Revenue growth: 11.640017498195213%
Rule of 40 score: 12.551270895330125
Market cap: 61947551744 (Large Cap ($10B-$200B))
P/E ratio: 0.15183647871401104
Debt to equity: 0.41409999999999997
Free cash flow (dilution adjusted): 23251621.449766852
Operating income: 65695072.06443408
Net income: 39218471.81008902
Long score: 12 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for IBM (quarterly, report date 2026-06-30)
Altman Z-score: 2.580543258584611 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 220.54263565891472%
Earnings yield: 1.0983505769383914%
Return on net tangible assets: -6.114489565812092%
Capitalized R&D asset: 4488620000
ROCI (R&D adjusted): 2.429930199101802%
Rosenberg metric: 0.44040497008743673
Free cash flow margin: 9.998834634657966%
Revenue growth: 7.821825720927309%
Rule of 40 score: 17.820660355585275
Market cap: 201795764224 (Mega Cap (>= $200B))
P/E ratio: 24.952085181898845
Debt to equity: 1.8897
Free cash flow (dilution adjusted): 1716000000
Operating income: 2845000000
Net income: 2165000000
Long score: 7 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for ILT.DE (quarterly, report date 2026-03-31)
Altman Z-score: 6.435227055301805 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 31.539888682745826%
Earnings yield: 1.279793315358983%
Return on net tangible assets: -31.87808896210873%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 9.329552730266165%
Free cash flow margin: 12.699203187250996%
Revenue growth: -1.8812606889811874%
Rule of 40 score: 10.817942498269808
Market cap: 71378370560 (Large Cap ($10B-$200B))
P/E ratio: 26.792036471215866
Debt to equity: 2.8322000000000003
Free cash flow (dilution adjusted): 510000000
Operating income: 1020000000
Net income: 768000000
Long score: 6 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for JKLAKSHMI.NS (quarterly, report date 2026-03-31)
Altman Z-score: 1.7243275988178226 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 3.1153798793252063%
Earnings yield: 0.0253432848484296%
Return on net tangible assets: 5.404111007559284%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.000825820149122%
Revenue growth: 13.89026307889896%
Rule of 40 score: 13.89026307889896
Market cap: 71072686080 (Large Cap ($10B-$200B))
P/E ratio: 0.1752930239438147
Debt to equity: 0.6659
Operating income: 21449766.850360323
Net income: 13253497.244595168
Long score: 1 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for JKLAKSHMI.NS (annual, report date 2026-03-31)
Altman Z-score: 2.4801138486438075 (Grey Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 10.575668021179656%
Earnings yield: 0.0860319375180781%
Return on net tangible assets: 1.5812364088226154%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.186795476818471%
Free cash flow margin: 5.524034288435121%
Revenue growth: -0.41787303715115537%
Rule of 40 score: 5.106161251283965
Market cap: 71072686080 (Large Cap ($10B-$200B))
P/E ratio: 0.1752930239438147
Debt to equity: 0.6659
Free cash flow (dilution adjusted): 39589868.58838491
Operating income: 72814752.01356506
Net income: 43727214.92157694
Long score: 7 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for KIT.OL (quarterly, report date 2026-03-31)
Altman Z-score: 23.5944125904556 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 9.030217849613493%
Earnings yield: 0.012933565060273603%
Return on net tangible assets: 15.357561547479484%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.45300233396987%
Free cash flow margin: 1.8335166850018336%
Revenue growth: 20.4741449416539%
Rule of 40 score: 22.307661626655733
Market cap: 20055015424 (Large Cap ($10B-$200B))
P/E ratio: 3.099931928297807
Debt to equity: 0.35710000000000003
Free cash flow (dilution adjusted): 513874.61459403904
Operating income: 2641315.5190133606
Net income: 2055498.4583761562
Long score: 8 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for ORVR3.SA (quarterly, report date 2026-03-31)
Altman Z-score: 2.360846518198993 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 2.6913510845870006%
Earnings yield: 0.17197712202539517%
Return on net tangible assets: 7.597027334968846%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.1364896934940156%
Free cash flow margin: 23.928946827918665%
Revenue growth: 30.500015198537582%
Rule of 40 score: 54.42896202645625
Market cap: 10752477184 (Large Cap ($10B-$200B))
P/E ratio: 13.302393200626259
Debt to equity: 1.4828999999999999
Free cash flow (dilution adjusted): 15061406.844106464
Operating income: 15655323.19391635
Net income: 4300760.456273764
Long score: 3 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for POKARNA.NS (annual, report date 2026-03-31)
Altman Z-score: 3.6710145001524714 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 9.459049369053336%
Earnings yield: 0.0390775048775157%
Return on net tangible assets: -22.830596823049692%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 9.309344714026889%
Free cash flow margin: -25.09288968576791%
Revenue growth: -44.288440529627806%
Rule of 40 score: -69.38133021539572
Market cap: 28725204992 (Large Cap ($10B-$200B))
P/E ratio: 0.33668765818523705
Debt to equity: 0.5346
Free cash flow (dilution adjusted): -15200900.805426028
Operating income: 12962155.57439593
Net income: 8542793.556591777
Long score: 3 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for POKARNA.NS (quarterly, report date 2026-03-31)
Altman Z-score: 3.2261231745888224 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 2.5514884494651047%
Earnings yield: 0.010540784643232723%
Return on net tangible assets: 4.396510917278372%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.5111070450312925%
Revenue growth: 3.7967273871225533%
Rule of 40 score: 3.7967273871225533
Market cap: 28725204992 (Large Cap ($10B-$200B))
P/E ratio: 0.33668765818523705
Debt to equity: 0.5346
Operating income: 3496417.973717677
Net income: 2714412.8868164476
Long score: 3 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for SYNGENE.NS (quarterly, report date 2026-03-31)
Altman Z-score: 5.60260180120804 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 4.664812421979369%
Earnings yield: 0.01455142881252684%
Return on net tangible assets: 5.409689057579612%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.8710380924687406%
Revenue growth: 7.521646439841684%
Rule of 40 score: 7.521646439841684
Market cap: 163677913088 (Large Cap ($10B-$200B))
P/E ratio: 0.5199152409783072
Debt to equity: 0.0947
Operating income: 22573124.205171682
Net income: 15674014.412886817
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for SYNGENE.NS (annual, report date 2026-03-31)
Altman Z-score: 6.128547624559848 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 12.20516414445588%
Earnings yield: 0.03807282289775215%
Return on net tangible assets: 8.875727304957143%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.128307647571969%
Free cash flow margin: 14.005594483064227%
Revenue growth: -6.820731743578545%
Rule of 40 score: 7.184862739485682
Market cap: 163677913088 (Large Cap ($10B-$200B))
P/E ratio: 0.5199152409783072
Debt to equity: 0.0947
Free cash flow (dilution adjusted): 53592623.99321747
Operating income: 59061042.81475201
Net income: 33562950.402713016
Long score: 8 | Short score: 0
Recommendation: Long
Stock screener scorecard for VRT (quarterly, report date 2026-03-31)
Altman Z-score: 7.995973828965165 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 10.922739753633776%
Earnings yield: 0.38612846985130794%
Return on net tangible assets: 92.4373795761079%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.3817224987277985%
Free cash flow margin: 23.99698056237026%
Revenue growth: -8.003472222222221%
Rule of 40 score: 15.99350834014804
Market cap: 111529828352 (Large Cap ($10B-$200B))
P/E ratio: 62.947236180904525
Debt to equity: 0.7691
Free cash flow (dilution adjusted): 635800000
Operating income: 433600000
Net income: 390100000
Long score: 8 | Short score: 1
Recommendation: Long
Stock screener scorecard for 4245.T (annual, report date 2025-12-31)
Altman Z-score: 1.684737369435381 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 11.188319113378489%
Earnings yield: 0.0431226740959138%
Return on net tangible assets: -4.693431496606467%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.743820771946915%
Free cash flow margin: -0.1303780964797914%
Revenue growth: 3.5930284666471537%
Rule of 40 score: 3.462650370167362
Market cap: 8857020547.745344 (Mid Cap ($2B-$10B))
P/E ratio: 19.2126259170181
Debt to equity: 1.829822558887621
Free cash flow (dilution adjusted): -402787.5455533534
Operating income: 8132472.348315326
Net income: 2947381.8809539033
Long score: 2 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for 4PN.DE (annual, report date 2025-12-31)
Altman Z-score: 2.415475572415983 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 37.173489278752434%
Earnings yield: 3.069205367870605%
Return on net tangible assets: -30.77402467904774%
Capitalized R&D asset: 1247310000
ROCI (R&D adjusted): 6.163673847580816%
Rosenberg metric: -0.5204081632653061
Free cash flow margin: 9.412792569089989%
Revenue growth: -3.2864893711642797%
Rule of 40 score: 6.12630319792571
Market cap: 44460481466.47059 (Large Cap ($10B-$200B))
P/E ratio: 28.015426254864895
Debt to equity: 0.867143261608154
Free cash flow (dilution adjusted): 2047000000
Operating income: 1907000000
Net income: 1587000000
Long score: 6 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 5942.T (annual, report date 2025-11-30)
Altman Z-score: 1.6726655802030472 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 3.226380874535358%
Earnings yield: 0.02258339009730173%
Return on net tangible assets: -7.5344664589629105%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.370557814525743%
Free cash flow margin: -0.18969443625841328%
Revenue growth: -5.961540687044303%
Rule of 40 score: -6.151235123302716
Market cap: 9969995321 (Mid Cap ($2B-$10B))
Debt to equity: 0.5143469483403621
Free cash flow (dilution adjusted): -337951.11338622984
Operating income: 4274564.88354236
Net income: -4283599.948809829
Long score: 1 | Short score: 9
Recommendation: Short
Stock screener scorecard for 6492.T (annual, report date 2024-11-30)
Altman Z-score: 4.127440523955153 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 12.189105858170608%
Earnings yield: 0.04038733058656213%
Return on net tangible assets: 10.355082912761358%
Capitalized R&D asset: 173952.2286934031
ROCI (R&D adjusted): 9.625425111340796%
Rosenberg metric: 20.767445299215137
Free cash flow margin: 23.430040396621372%
Revenue growth: 7.274483545692063%
Rule of 40 score: 30.704523942313436
Market cap: 8729439920.41 (Mid Cap ($2B-$10B))
P/E ratio: 7.921451833402904
Debt to equity: 0.07675105107791395
Free cash flow (dilution adjusted): 12661242.30998214
Operating income: 7845471.985182246
Net income: 7289806.178474566
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 7544.T (annual, report date 2026-02-28)
Altman Z-score: 6.7847661705687905 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 21.521739130434785%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 29.09500409500409%
Free cash flow margin: 7.174114838880785%
Revenue growth: 4.318483483823393%
Rule of 40 score: 11.492598322704179
Market cap: 4347683788 (Mid Cap ($2B-$10B))
P/E ratio: 4.8905329448818895
Debt to equity: 0
Free cash flow (dilution adjusted): 6942127.5503657125
Operating income: 9117156.422430385
Net income: 5703836.776594379
Long score: 8 | Short score: 0
Recommendation: Long
Stock screener scorecard for 8093.HK (annual, report date 2025-06-30)
Altman Z-score: 1.8082326012059156 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -44.17252982563475%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -12.774407541570291%
Free cash flow margin: -21.04386951631046%
Revenue growth: -64.4908076980967%
Rule of 40 score: -85.53467721440717
Market cap: 175153536 (Micro Cap ($50M-$300M))
Debt to equity: 0.24743259188043532
Free cash flow (dilution adjusted): -1191592.356687898
Operating income: -745732.4840764331
Net income: -2585987.261146497
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for ADPT (annual, report date 2025-12-31)
Altman Z-score: 2.3619950269648298 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -45.44879963300882%
Capitalized R&D asset: 203046120
ROCI (R&D adjusted): -11.125950611795467%
Rosenberg metric: 0.9590784144221149
Free cash flow margin: -36.258737219109236%
Revenue growth: 54.7723754868488%
Rule of 40 score: 18.513638267739566
Market cap: 2599120926.08 (Mid Cap ($2B-$10B))
Debt to equity: 0.35176732547855344
Free cash flow (dilution adjusted): -100428000
Operating income: -57123000
Net income: -59457000
Long score: 5 | Short score: 8
Recommendation: Short
Stock screener scorecard for BFRG (annual, report date 2025-12-31)
Altman Z-score: -3.9337631714858516 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -304.08907055046296%
Capitalized R&D asset: 3762088.17
ROCI (R&D adjusted): -112.12223227676519%
Rosenberg metric: 0.009846779398767129
Free cash flow margin: -5599.465158138339%
Rule of 40 score: -5599.465158138339
Market cap: 16316652.88 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -6532896
Operating income: -6594636
Net income: -6498068
Long score: 2 | Short score: 16
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for BPOP (annual, report date 2025-12-31)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 13.360964704099793%
Capitalized R&D asset: 0
Free cash flow margin: 21.46653118185554%
Revenue growth: 8.873118648428454%
Rule of 40 score: 30.339649830283996
Market cap: 7867736432.389999 (Mid Cap ($2B-$10B))
P/E ratio: 9.443259248702828
Debt to equity: 0.2467442002253452
Free cash flow (dilution adjusted): 654050000
Net income: 833159000
Long score: 6 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for CLDX (annual, report date 2025-12-31)
Altman Z-score: 17.93107772996403 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -51.620781039051955%
Capitalized R&D asset: 393596130
ROCI (R&D adjusted): -23.535090062142437%
Free cash flow margin: -16173.203883495145%
Revenue growth: -77.99145299145299%
Rule of 40 score: -16251.195336486599
Market cap: 2131844675.52 (Mid Cap ($2B-$10B))
Debt to equity: 0.004431250177838058
Free cash flow (dilution adjusted): -249876000
Operating income: -287367000
Net income: -258757000
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for CNOB (annual, report date 2025-12-31)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 6.887120297065688%
Capitalized R&D asset: 0
Free cash flow margin: 25.478375598547885%
Revenue growth: 43.224963550640936%
Rule of 40 score: 68.70333914918882
Market cap: 1301466224.72 (Small Cap ($300M-$2B))
P/E ratio: 16.178738047064382
Debt to equity: 0.7231742662107364
Free cash flow (dilution adjusted): 96361000
Net income: 80443000
Long score: 3 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for EP (annual, report date 2025-12-31)
Altman Z-score: -2.9979959951585666 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -48.21940237413017%
Free cash flow margin: -31.014823261117446%
Revenue growth: -22.334748745430186%
Rule of 40 score: -53.34957200654763
Market cap: 120968300.16 (Micro Cap ($50M-$300M))
Debt to equity: -3.5555796786799827
Free cash flow (dilution adjusted): -10608000
Operating income: -20026000
Net income: -72074000
Long score: 1 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for GSBC (annual, report date 2025-12-31)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 10.87816417810384%
Capitalized R&D asset: 0
Free cash flow margin: 29.744204810606888%
Revenue growth: 4.358967356673403%
Rule of 40 score: 34.10317216728029
Market cap: 661774195.1999999 (Small Cap ($300M-$2B))
P/E ratio: 9.324309176729178
Debt to equity: 0.5607411110377504
Free cash flow (dilution adjusted): 68199000
Net income: 70973000
Long score: 6 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for OMG.L (annual, report date 2025-09-30)
Altman Z-score: 1.834180842330968 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 14194982.039112283
ROCI (R&D adjusted): -0.5121828489489042%
Rosenberg metric: 0.3380689466011775
Free cash flow margin: 5.800241211417339%
Revenue growth: 9.455254719250487%
Rule of 40 score: 15.255495930667827
Market cap: 447737.336 (Nano Cap (< $50M))
Debt to equity: 0.05323268393376426
Free cash flow (dilution adjusted): 3509459.4594594594
Operating income: -528378.3783783783
Net income: -920270.2702702703
Long score: 5 | Short score: 8
Recommendation: Neutral
Stock screener scorecard for QMC.V (annual, report date 2025-08-31)
Altman Z-score: -2.7062323081546698 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -22.66644759020283%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -6.499204856973487%
Rule of 40 score: 0
Market cap: 5204041.2 (Nano Cap (< $50M))
Debt to equity: 0.04870760994900029
Free cash flow (dilution adjusted): -326777.3722627737
Operating income: -164934.30656934305
Net income: -165358.39416058394
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for RCS (annual, report date 2025-06-30)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 14.778132380463017%
Capitalized R&D asset: 0
Free cash flow margin: 110.57747466377717%
Revenue growth: 2.321789604121829%
Rule of 40 score: 112.899264267899
Market cap: 304586331.15000004 (Small Cap ($300M-$2B))
P/E ratio: 9.71598236466873
Debt to equity: 0.44855301676794057
Free cash flow (dilution adjusted): 34697000
Net income: 31349000
Long score: 5 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for SAGARDEEP.NS (annual, report date 2025-03-31)
Altman Z-score: 6.948301893012985 (Safe Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 2.011643725992317%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.736793706260444%
Free cash flow margin: 3.073177141337145%
Revenue growth: 22.232372631155574%
Rule of 40 score: 25.305549772492718
Market cap: 489201255.514996 (Small Cap ($300M-$2B))
P/E ratio: 25.43154790574943
Debt to equity: 0.19214777520297419
Free cash flow (dilution adjusted): 448410.10053776007
Operating income: 174631.7512274959
Net income: 224877.25040916528
Long score: 8 | Short score: 2
Recommendation: Long
Stock screener scorecard for SCY.V (annual, report date 2025-12-31)
Altman Z-score: -142.16214471217106 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 26082297.810218975 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -374213
Operating income: -423032
Net income: -2174238
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for SPT (annual, report date 2025-12-31)
Altman Z-score: 0.6414537915995387 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 196402480
ROCI (R&D adjusted): -7.926322142484767%
Rosenberg metric: 0.3932038834951456
Free cash flow margin: -8.610700102940244%
Revenue growth: 12.721848300600136%
Rule of 40 score: 4.111148197659892
Market cap: 612143359.87 (Small Cap ($300M-$2B))
Debt to equity: 0.26899253768029024
Free cash flow (dilution adjusted): -39398000
Operating income: -43453000
Net income: -43327000
Long score: 2 | Short score: 11
Recommendation: Short
Stock screener scorecard for SUPN (annual, report date 2025-12-31)
Altman Z-score: 5.590280032068278 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 209354010
ROCI (R&D adjusted): -2.480452546582966%
Rosenberg metric: 0.5558935990293761
Free cash flow margin: 1.800120174921274%
Revenue growth: 8.633051130448449%
Rule of 40 score: 10.433171305369722
Market cap: 2884574133.7000003 (Mid Cap ($2B-$10B))
Debt to equity: 0.03859513955735725
Free cash flow (dilution adjusted): 12942000
Operating income: -36864000
Net income: -38550000
Long score: 6 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 0601.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 34963108 (Nano Cap (< $50M))
Debt to equity: -8.803378416937742
Long score: 1 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 0601.HK (annual, report date 2025-12-31)
Altman Z-score: -1.2721154504166243 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -14.233052336338167%
Free cash flow margin: -6.449899651204952%
Revenue growth: -19.524674744175165%
Rule of 40 score: -25.974574395380117
Market cap: 34963108 (Nano Cap (< $50M))
Debt to equity: -8.803378416937742
Free cash flow (dilution adjusted): -1623393.3161953727
Operating income: -11766709.511568123
Net income: -41178277.63496144
Long score: 1 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for 0736.HK (quarterly, report date 2025-09-30)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 62837524 (Micro Cap ($50M-$300M))
Debt to equity: 0.32130000000000003
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 0751.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 8251419648 (Mid Cap ($2B-$10B))
P/E ratio: 2.882849798016893
Debt to equity: 0.7918999999999999
Long score: 1 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 1679.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 297823104 (Micro Cap ($50M-$300M))
Debt to equity: -3.3460054994740434
Long score: 1 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 1679.HK (annual, report date 2025-12-31)
Altman Z-score: -3.7273083262348177 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 4193553.6500780303
ROCI (R&D adjusted): -14.585378766642512%
Rosenberg metric: 0.6184097642948746
Free cash flow margin: -6.3234785615491%
Revenue growth: -21.086059110883717%
Rule of 40 score: -27.40953767243282
Market cap: 297823104 (Micro Cap ($50M-$300M))
Debt to equity: -3.3460054994740434
Free cash flow (dilution adjusted): -836000
Operating income: -1397000
Net income: -3379142.8571428573
Long score: 2 | Short score: 13
Recommendation: Short
Stock screener scorecard for 2267.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 790070951936 (Mega Cap (>= $200B))
P/E ratio: 0.11038499364315231
Debt to equity: 0.192
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2311.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 6813028864 (Mid Cap ($2B-$10B))
P/E ratio: 0.1032552345986753
Debt to equity: 0.1085
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2481.HK (annual, report date 2025-12-31)
Altman Z-score: 0.5316648648430414 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -21.185973650709805%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.58667329964897%
Free cash flow margin: 24.590603107436003%
Revenue growth: -6.685834802828833%
Rule of 40 score: 17.90476830460717
Market cap: 769080000 (Small Cap ($300M-$2B))
P/E ratio: 0.4615564384201916
Debt to equity: 0.4428
Free cash flow (dilution adjusted): 46158142.85714286
Operating income: 43398285.71428572
Net income: 34408428.571428575
Long score: 6 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 2481.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 769080000 (Small Cap ($300M-$2B))
P/E ratio: 0.4615564384201916
Debt to equity: 0.4428
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2625.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 485417504 (Small Cap ($300M-$2B))
P/E ratio: 2.766556494062921
Debt to equity: 0.9163
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3360.HK (quarterly, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 31490877440 (Large Cap ($10B-$200B))
P/E ratio: 0.8373142250530785
Debt to equity: 4.465199999999999
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 3461.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 4052319488 (Mid Cap ($2B-$10B))
P/E ratio: 0.14850989164540981
Debt to equity: 1.0802
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3696.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 27242588160 (Large Cap ($10B-$200B))
Debt to equity: 0.0132
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 3696.HK (annual, report date 2025-12-31)
Altman Z-score: 428.4576841765402 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -77.56303692898204%
Capitalized R&D asset: 22507258.954363555
ROCI (R&D adjusted): -11.220961154521873%
Rosenberg metric: -0.34655706167385913
Free cash flow margin: -153.3597681324348%
Revenue growth: -34.64777741312475%
Rule of 40 score: -188.00754554555954
Market cap: 27242588160 (Large Cap ($10B-$200B))
Debt to equity: 0.0132
Free cash flow (dilution adjusted): -11085861.18251928
Operating income: -7975064.267352185
Net income: -45284832.904884316
Long score: 4 | Short score: 14
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for 3815.T (quarterly, report date 2026-02-28)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 4808012288 (Mid Cap ($2B-$10B))
Debt to equity: 1.4291
Long score: 0 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 3918.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 15524696064 (Large Cap ($10B-$200B))
P/E ratio: 1.0656695489600372
Debt to equity: 0.0766
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 5852.T (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 17483155456 (Large Cap ($10B-$200B))
P/E ratio: 0.03411793115532795
Debt to equity: 0.7049
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 6538.T (annual, report date 2026-03-31)
Altman Z-score: 4.701394687118506 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 108.73460246360584%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 23.135755258126196%
Free cash flow margin: 17.32499022291748%
Revenue growth: 11.481515283331774%
Rule of 40 score: 28.806505506249255
Market cap: 4871964672 (Mid Cap ($2B-$10B))
P/E ratio: 0.04478162372899215
Debt to equity: 0.22460000000000002
Free cash flow (dilution adjusted): 5543043.0430430425
Operating income: 4542042.042042042
Net income: 4260510.510510511
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 6538.T (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 4871964672 (Mid Cap ($2B-$10B))
P/E ratio: 0.04478162372899215
Debt to equity: 0.22460000000000002
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 6634.T (quarterly, report date 2026-02-28)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 3236484096 (Mid Cap ($2B-$10B))
Debt to equity: 1.1320999999999999
Long score: 0 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 6933.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 526443456 (Small Cap ($300M-$2B))
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 6933.HK (annual, report date 2025-12-31)
Altman Z-score: 35.53351434394921 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -57.40048015186198%
Capitalized R&D asset: 3638098.0248870836
ROCI (R&D adjusted): -21.884023043713704%
Rosenberg metric: 0.6535145856513956
Free cash flow margin: -110.4878904878905%
Revenue growth: -33.47886440981551%
Rule of 40 score: -143.966754897706
Market cap: 526443456 (Small Cap ($300M-$2B))
Debt to equity: 0
Free cash flow (dilution adjusted): -4496857.142857143
Operating income: -3181857.1428571427
Net income: -4138000
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for 7057.T (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 2795025152 (Mid Cap ($2B-$10B))
P/E ratio: 0.12041653004021911
Debt to equity: 0.0426
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7057.T (annual, report date 2026-03-31)
Altman Z-score: 2.740645416635406 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 19.734911427685727%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.521334593297957%
Free cash flow margin: 3.3766798364481425%
Revenue growth: -3.052754757248811%
Rule of 40 score: 0.32392507919933156
Market cap: 2795025152 (Mid Cap ($2B-$10B))
P/E ratio: 0.12041653004021911
Debt to equity: 0.0426
Free cash flow (dilution adjusted): 1777533.7837837837
Operating income: 953390.8908908908
Net income: 1048317.067067067
Long score: 8 | Short score: 1
Recommendation: Long
Stock screener scorecard for 7187.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 24106938368 (Large Cap ($10B-$200B))
P/E ratio: 0.05562124851464953
Debt to equity: 0.7648
Long score: 1 | Short score: 2
Recommendation: Neutral